Abstract:Background: Patient-derived organoids are invaluable for fundamental and translational cancer research and holds great promise for personalized medicine. However, the shortage of available analysis methods, which are often single-time point, severely impede the potential and routine use of organoids for basic research, clinical practise, and pharmaceutical and industrial applications. Methods: Here, we developed a high-throughput compatible and automated live-cell image analysis software that allows for kinetic monitoring of organoids, named Organoid Brightfield Identification-based Therapy Screening (OrBITS), by combining computer vision with a convolutional network machine learning approach. The OrBITS deep learning analysis approach was validated against current standard assays for kinetic imaging and automated analysis of organoids. A drug screen of standard-of-care lung and pancreatic cancer treatments was also performed with the OrBITS platform and compared to the gold standard, CellTiter-Glo 3D assay. Finally, the optimal parameters and drug response metrics were identified to improve patient stratification. Results: OrBITS allowed for the detection and tracking of organoids in routine extracellular matrix domes, advanced Gri3D®-96 well plates, and high-throughput 384-well microplates, solely based on brightfield imaging. The obtained organoid Count, Mean Area, and Total Area had a strong correlation with the nuclear staining, Hoechst, following pairwise comparison over a broad range of sizes. By incorporating a fluorescent cell death marker, intra-well normalization for organoid death could be achieved, which was tested with a 10-point titration of cisplatin and validated against the current gold standard ATP-assay, CellTiter-Glo 3D. Using this approach with OrBITS, screening of chemotherapeutics and targeted therapies revealed further insight into the mechanistic action of the drugs, a feature not achievable with the CellTiter-Glo 3D assay. Finally, we advise the use of the growth rate-based normalised drug response metric to improve accuracy and consistency of organoid drug response quantification. Conclusion: Our findings validate that OrBITS, as a scalable, automated live-cell image analysis software, would facilitate the use of patient-derived organoids for drug development and therapy screening. The developed wet-lab workflow and software also has broad application potential, from providing a launching point for further brightfield-based assay development to be used for fundamental research, to guiding clinical decisions for personalized medicine.

OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics

OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data

Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification

Analysis of organoid and immune cell co-cultures by machine learning-empowered image cytometry

A survey on Organoid Image Analysis Platforms

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening

Deep learning based characterization of human organoids using optical coherence tomography

Non-invasive label-free imaging analysis pipeline for in situ characterization of 3D brain organoids

A Deep Learning Model for Detection and Tracking in High-Throughput Images of Organoid

Automated detection and growth tracking of 3D bio-printed organoid clusters using optical coherence tomography with deep convolutional neural networks

Segmentation and Multi-Timepoint Tracking of 3D Cancer Organoids from Optical Coherence Tomography Images Using Deep Neural Networks

D-CryptO: Deep learning-based analysis of colon organoid morphology from brightfield images

OrgDyn: feature- and model-based characterization of spatial and temporal organoid dynamics

Long-term three-dimensional high-resolution imaging of live unlabeled small intestinal organoids via low-coherence holotomography

ISCO: Intelligent Framework for Accurate Segmentation and Comparative Analysis of Organoids

An Automated Organoid Platform With Inter-Organoid Homogeneity And Inter-Patient Heterogeneity

SegmentAnything helps microscopy images based automatic and quantitative organoid detection and analysis

Development of an automated 3D high content cell screening platform for organoid phenotyping

A large and diverse brain organoid dataset of 1,400 cross-laboratory images of 64 trackable brain organoids

Sketch the Organoids from Birth to Death – Development of an Intelligent OrgaTracker System for Multi-Dimensional Organoid Analysis and Recreation

Live Organoid Cyclic Imaging